Submitted by Anonymous (not verified) on 19 March 2025 - 15:56
Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Date of authorisation: 18/12/2018, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Namuscla, mexiletine hcl, Date of authorisation: 18/12/2018, Revision: 6, Status: Authorised